CFDB - Cystic Fibrosis DataBase

All subcategories » published RCT

Microbiological efficacy of early MRSA treatment in cystic fibrosis in a randomised controlled trial.

primary studies  published RCT

Details
  • 2017
  • Muhlebach MS

Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial.

primary studies  published RCT

Details
  • 2017
  • Nenna R

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled phase 3 trial.

primary studies  published RCT

Details
  • 2017
  • Ratjen F

Tezacaftor-Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis.

primary studies  published RCT

Details
  • 2017
  • Rowe SM

Lumacaftor/Ivacaftor Treatment of Patients with Cystic Fibrosis Heterozygous for F508del-CFTR.

primary studies  published RCT

Details
  • 2017
  • Rowe SM

Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del.

primary studies  published RCT

Details
  • 2017
  • Taylor-Cousar JL

Long-Term Pulmonal Therapy of Cystic Fibrosis-Patients with Amitriptyline.

primary studies  published RCT

Details
  • 2016
  • Adams C

A randomized controlled trial to evaluate the lung clearance index as an outcome measure for early phase studies in patients with cystic fibrosis.

primary studies  published RCT

Details
  • 2016
  • Amin R

Nutritional Status Improved in Cystic Fibrosis Patients with the G551D Mutation After Treatment with Ivacaftor.

primary studies  published RCT

Details
  • 2016
  • Borowitz D

Pilot Randomized Controlled Trial Evaluating the Effect of Hypertonic Saline With and Without Hyaluronic Acid in Reducing Inflammation in Cystic Fibrosis.

primary studies  published RCT

Details
  • 2016
  • Brivio A